Sg Americas Securities, LLC Pulmonx Corp Transaction History

Sg Americas Securities, LLC

  • $20.8 Billion
  • Q1 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024
BUY
$7.89 - $13.14 $72,461 - $120,677
9,184 New
9,184 $117,000
Q2 2023

Jul 10, 2023
BUY
$10.78 - $13.65 $6,985 - $8,845
648 Added 5.86%
11,711 $154,000
Q1 2023

Apr 28, 2023
BUY
$7.49 - $12.54 $82,861 - $138,730
11,063 New
11,063 $124,000
Q3 2022

Oct 31, 2022
SELL
$15.35 - $23.99 $150,552 - $235,293
-9,808 Reduced 33.2%
19,733 $329,000
Q2 2022

Jul 29, 2022
BUY
$14.0 - $27.95 $413,574 - $825,670
29,541 New
29,541 $435,000
Q4 2021

Feb 07, 2022
SELL
$29.72 - $45.1 $285,609 - $433,411
-9,610 Closed
0 $0
Q3 2021

Nov 01, 2021
BUY
$35.98 - $44.48 $345,767 - $427,452
9,610 New
9,610 $346,000

Others Institutions Holding LUNG

# of Institutions
124
Shares Held
30.8M
Call Options Held
1.2K
Put Options Held
1.2K
View Full List

About Pulmonx Corp

LUNG Quotes by TradingView
  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email